Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GSK plc American Depositary Shares (Each representing two Ordinary Shares) (NY:GSK)

58.20 -0.93 (-1.57%)
Streaming Delayed Price Updated: 3:18 PM EST, Mar 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about GSK plc American Depositary Shares (Each representing two Ordinary Shares)

< Previous 1 2
...
28 29 30 31 32 33 34 35 36
...
44 45 Next >
News headline image
Sanofi-GSK's Next-Gen COVID-19 Booster Shows Potential Against Variants Of Concern ↗
 
Via Benzinga
News headline image
Morning Brief: Top Financial Stories Dominating on Friday, June 10 ↗
Reuters Rebranded McDonald’s Restaurants To Reopen In Russia 
Via Benzinga
News headline image
GSK Shows Positive Pivotal Phase III Data For Its RSV Vaccine Candidate ↗
 
Via Benzinga
Breakthroughs In Treating Killer Diseases Could Lengthen Life
Palm Beach, FL – June 7, 2022 – FinancialNewsMedia.com News Commentary – According to the World Health Organization, top global killers include heart failure, COPD, cancers, Alzheimer’s, neonatal... 
Via FinancialNewsMedia
Topics Death
News headline image
FDA Approves GSK's Measles Vaccine ↗
 
Via Benzinga
News headline image
GlaxoSmithKline: Dividend Insights ↗
Wednesday marks the last chance for investors to receive the next dividend payout from GlaxoSmithKline (NYSE:GSK). 
Via Benzinga
News headline image
GSK announces US FDA approval of PRIORIX for the prevention of measles, mumps and rubella in individuals 12 months of age and older
From GSK plc
Via Business Wire
News headline image
Morning Brief: Top Financial Stories Dominating on Monday, June 6 ↗
Reuters 
Via Benzinga
News headline image
The Week Ahead In Biotech (June 5-11): Adcom Test For Novavax, ASCO Presentations, Enzo Biochem Earnings And More ↗
Biotech stocks reversed course along with the broader market and closed the week ending June 3 lower. The sector's lean run thus got extended. 
Via Benzinga
News headline image
Week In Review: Vivo Raises $600 Million In First Tranche Of China PE Fund ↗
Vivo Capital held its first closing of a yuan-denominated private equity fund at $600 million, with a target of bringing the fund to $1.5 billion. Meanwhile, ProfoundBio closed a $70 million Series A+... 
Via Talk Markets
News headline image
6 Biotech Stocks to Buy Now Ahead of These June Catalysts ↗
These biotech stocks face some key make-or-break events in June that could have big implication for their futures. 
Via InvestorPlace
News headline image
3 Undervalued Dividend Growth Stocks ↗
Investors who focus on a strategy of dividend growth stocks have performed better than some broader stock market indices. 
Via InvestorPlace
News headline image
GSK Confirms Consumer Healthcare Unit Spin-off: What Investors Should Know ↗
Close on the heels of an M&A deal, GlaxoSmithKline plc (NYSE: GSK) confirmed the spin-off of the consumer healthcare business it jointly owns with U.S. pharma giant Pfizer, Inc. 
Via Benzinga
News headline image
Morning Brief: Top Financial Stories Dominating on Wednesday, June 1 ↗
Reuters Redbird Capital Buys Italian Football Club AC Milan 
Via Benzinga
News headline image
Pfizer To Quit GSK's Consumer Health JV Following Its Spin-Off ↗
 
Via Benzinga
News headline image
3 Biotech Stocks to Buy Before They Boom ↗
It could be a “never-before, never-after opportunity” to buy into these biotech stocks that trade at very attractive valuations. 
Via InvestorPlace
News headline image
Unilever Jumps After Nelson Peltz Joins Board ↗
Unilever plc (NYSE: UL) shares traded higher by 8% on Tuesday after the company announced activist investor Nelson Peltz is joining the company's board of directors. 
Via Benzinga
News headline image
GlaxoSmithKline Announces $3.3 Billion Buyout To Square Off With Pfizer, Merck ↗
The deal could vastly expand GlaxoSmithKline's vaccine offerings. 
Via Investor's Business Daily
News headline image
Morning Brief: Top Financial Stories Dominating on Tuesday, May 31 ↗
CNBC Opportunities In Crypto Crash? Top Crypto Firms Hunt For Takeovers 
Via Benzinga
News headline image
GSK To Scoop Clinical Stage US Biotech Affinivax For $3.3B To Shore Up Vaccine Business ↗
 
Via Benzinga
News headline image
Unilever To Add This Activist Investor To Board - What's The Catch? ↗
 
Via Benzinga
News headline image
Dow Up Nearly 300 Points, Eyeing Seventh-Straight Daily Win ↗
An upbeat core personal consumption expenditures price index for April is boosting investor sentiment at midday after it showed slowing inflation. 
Via Talk Markets
Nicotine Surges as Smoking Sags
Via Investor Brand Network
Nicotine Surges as Smoking Sags
NetworkNewsWire Editorial Coverage New York, NY – May 24, 2022 – Seems like yesterday people were smoking cigarettes everywhere; many people still have memories of Grandpa puffing on his Camels. It... 
Via FinancialNewsMedia
News headline image
GSK Turnaround Story ↗
GSK is already gearing up for what it hopes will be a bright future. On April 13, GlaxoSmithKline announced a $1.9 billion deal to purchase a U.S. biotech company, Sierra Oncology. 
Via Talk Markets
News headline image
Large Cap Biopharmaceuticals: Provide Growth, Value And Yield ↗
Now that all major biopharmaceutical earnings are in, we can review the financial metrics and see if our portfolio needs re-balancing. 
Via Talk Markets
News headline image
HC Wainwright Says This Stock Is Well Capitalized For Value Realization Of Pipeline, Despite COVID-19 Uncertainty ↗
 
Via Benzinga
News headline image
Why Roche's Flop In Lung Cancer Hammered Arcus, Iteos And Others ↗
Roche isn't the only company working on an anti-TIGIT molecule. 
Via Investor's Business Daily
News headline image
Dividend Income Update April 2022 ↗
With May already underway it is time for all dividend income investors to look back at the previous month and see how much passive dividend income their portfolios generated. 
Via Talk Markets
News headline image
GlaxoSmithKline Clocks 32% Topline Growth Buoyed By COVID-19 Therapy, Shingrix Vaccine ↗
 
Via Benzinga
< Previous 1 2
...
28 29 30 31 32 33 34 35 36
...
44 45 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.